Interferon-Gamma Release Assay Conversion and Reversion Reactions During Solid Organ Transplant Evaluation

Clin Infect Dis. 2024 Oct 30:ciae525. doi: 10.1093/cid/ciae525. Online ahead of print.

Chia-Yu Chiu^{1

2}, Maryam Mahmood^{1

3}, Lisa M Brumble⁴, Holenarasipur R Vikram⁵, Elitza S Theel⁶, Elena Beam^{1

3}

¹ Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
² Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado.
³ William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota.
⁴ Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida.
⁵ Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona.
⁶ Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

No abstract available

Keywords: Latent tuberculosis infection; QuantiFERON; T-SOPT.TB; pretransplant evaluation; solid organ transplantation.